Le Lézard
Classified in: Health
Subject: SVY

Global Surgical Robotics Market Expected to Grow Over $12.60 Billion by 2025, Reports BIS Research


EDINA, Minnesota, January 23, 2018 /PRNewswire/ --

According to a new market intelligence report by BIS Research, titled "Global Surgical Robotics Market- Analysis and Forecast, 2017-2025", the global surgical robotics market is anticipated to grow at a CAGR of 12 % during the forecast period 2017-2025, and expected to grow over $12.60 billion by 2025. As per the volume data, the surgical system is anticipated to grow at a CAGR of 10% during the forecast period, 2017-2025.

     (Logo: http://mma.prnewswire.com/media/495163/BIS_Research_Logo.jpg )

Rising incidence rate of chronic diseases, increasing geriatric population, growing demand of minimally invasive surgeries and miniature robotics, technological advancements in the field of medical surgeries, and substantial funding provided by various governmental organizations to perform research & development (R&D) activities in next-generation surgical robotic systems are the factors that are expected to fuel the demand for surgical robotic systems in the near future.

Browse 48 market Data Tables and 143 Figures spread through 369 Pages and in-depth TOC on "Global Surgical Robotics Market"

As per the Lancet Commission on Global Surgery, nearly one-third of the global disease burden can be attributed to surgically treatable conditions. Factors such as lack of infrastructure, insufficient numbers of trained surgeons and anesthesiologists, and the prohibitive costs of receiving care prevent billions of people, especially in the low and middle income countries from receiving the necessary care. An estimated 143 million additional surgical procedures are needed each year to save lives and prevent disability. Furthermore, for the developing countries, investing in surgery would save approximately $12.3 trillion in GDP by 2030.

The growing demand for technologically advanced and minimally invasive surgical procedures, both from the doctors' and patient's end, gave rise to the robotic assistive surgeries. Robotic surgery refers to a surgical procedure where surgeons use a computer to control small instruments attached to a robot. Hence, it is also known as computer guided minimally invasive surgery.

The shorter hospitalization times, reduced therapy requirements, less pain, and consequently reduced need for postsurgical pain or scarring medication, and negligible complications related to the incision are some of the additional benefits, which are propelling the adoption rate of surgical robotic systems across various hospitals and ambulatory surgical centers.

According to Abdul Wahid, a lead analyst at BIS Research, "With the advent of technologically advanced surgical robotic systems, the global market is expected to grow substantially to meet the rising needs of healthcare professionals confronting the surgeries of a large pool of patients, especially of the people with gynaecological, urological, orthopaedics, neurological, and orthopaedics disorders. The market for surgical systems by value is expected to grow at the CAGR of 12.3% during the forecast period, 2017-2025. Among all the surgical systems, the da Vinci surgical system accounted for the highest installation volume in 2016 and is anticipated to reach 1,123 installation units in 2025, growing at the CAGR of 8%. Furthermore, the market for da Vinci surgical system by value accounted for the highest market share in 2016 and is expected to grow at a CAGR of 10.9% during the forecast period, 2017-2025."

Research Highlights: 

Request for Sample Report: https://bisresearch.com/requestsample?id=486&type=download

This market intelligence report provides a multidimensional view of the global surgical robotics market in terms of market size and growth potential. This research report aims at answering various aspects of the global surgical robotics market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that is going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global surgical robotics market and assesses the factors governing the same.

Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities such as product launches, regulatory clearance, and certifications, partnerships, collaborations, business expansion as well as mergers and acquisitions. The research report provides a comprehensive analysis of product sales, manufacturers and trend analysis by segments and demand by geographical regions.

This report is a meticulous compilation of research on more than 120 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of more than 60 leading companies, market participants and vendors. The report also profiles 26 companies including several key players such as Intuitive Surgical Inc., Accuray Inc., Mazor Robotics Ltd., Medrobotics Corporation, Medtech SA, Renishaw plc, Stryker Corporation, Synaptive Medical Inc., Titan Medical Inc., Think Surgical Inc., TransEnterix Inc., and Smith & Nephew plc, among others.

Key questions answered in the report: 

Related Reports: 

Global Computer Aided Diagnostics Market, Analysis & Forecast, 2017-2025

Global Cancer Imaging Systems Market, Analysis & Forecast, 2017-2025

About BIS Research: 

BIS Research (Business Intelligence and Strategy Research) is a global B2B market intelligence and advisory firm which focuses on those emerging trends in technology which are likely to disrupt the dynamics of the market.

With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials & Chemicals, Aerospace and Defence, Automotive, Healthcare, Electronics & Semiconductors, Robotics & UAV and other emerging technologies.

Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management.

What distinguishes BIS Research from the rest of the players is that we don't simply provide data, but also complement it with valuable insights and actionable inputs for the success of our clients.

Contact:
Bhavya Banga
Email: [email protected]
BIS Researchtm
9100 West Bloomington Freeway,
Suite 159, Bloomington,
MN 55431

Visit our Blog @ http://bisresearch.com/blog/ 
Connect with us on LinkedIn @ https://www.linkedin.com/company/3720474 
Connect with us on Twitter@ https://twitter.com/BISResearch


These press releases may also interest you

at 22:03
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

at 22:00
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

at 21:45
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

at 21:30
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...



News published on and distributed by: